Masonic Cancer Center, University of Minnesota

What's Inside

Quick Links for:

Cancer Information Line
Ask about cancer, clinical trials, and how to make an appointment:
ccinfo@umn.edu
612-624-2620

Toll-free in IA, MN, ND, SD, WI: 1-888-CANCER MN
(1-888-226-2376)

A Comprehensive Cancer Center Designated by the National Cancer Institute
Print this page. Mail this link to a friend.

March 2008
Funding News and Opportunities

The following funding news and opportunities were collected recently by Cancer Center Pre-Award Services and published in Cancer Center Update, a weekly e-newsletter for members and staff.

Visit the Research Funding Resources page for links to resources you can use to search for funding as well as University resources essential to application processes.

March 18 and 25

No listings were published.

March 11

Cancer Center Internal Grants Program
University of Minnesota Cancer Center
Statement of Intent due Friday, March 14, 2008—must be submitted online
Application Receipt Date: Friday, April 18, 2008
Funding: Varies by program
Six internal grant programs are available through the Cancer Center. The goal of these programs is to foster the development of and provide support for novel research ideas that focus on a problem in cancer. In turn, the Cancer Center expects that internal funding will lead to nationally peer reviewed funding. The various internal grants programs are for Brainstorm, Cancer Population Sciences, Translational Breast Cancer Research, Translational Sarcoma Cancer Research, Transdisciplinary Tobacco Use Research Center (TTURC) and Leukemia Research. The Statement of Intent and details regarding each mechanism can be found on the Cancer Center Web site

The contact person at the Cancer Center is Aaron Schilz, Pre-Award Services Coordinator (schil226@umn.edu; 612-6243-0650).

FY08 Tuberous Sclerosis Complex Research Program (TSCRP)
Department of Defense
Concept Award
Application Receipt Date: Pre-Application - April 18, 2008; Application - May 9, 2008
Funding: $75,000 direct costs for 1 year
The Tuberous Sclerosis Complex Research Program (TSCRP) Concept Award supports (1) the exploration of an initial concept or theory that could give rise to a testable hypothesis, and/or (2) the development of novel preclinical tools needed to advance research in TSC. These tools may include, but are not limited to, animal models, antibodies, cell lines, assays, and reagents.
Idea Development Award
Application Receipt Date: Pre-Application - May 22, 2008; Application - June 12, 2008
Funding: $450,000 direct costs for up to 3 years
The Tuberous Sclerosis Complex Research Program (TSCRP) Idea Development Award supports innovative research aimed at understanding the pathogenesis of TSC and improving its diagnosis and treatment.
Clinical Research Award
Application Receipt Date: Pre-Application - May 22, 2008; Application - June 12, 2008
Funding: $300,000 direct costs for up to 3 years
The Tuberous Sclerosis Complex Research Program (TSCRP) Clinical Research Award supports TSC research projects performed by clinical researchers involved in the support of clinical care of individuals with TSC. Proposed research should have a direct link to TSC clinical outcomes.
Career Transition Award
Application Receipt Date: Pre-Application - May 22, 2008; Application - June 12, 2008
Funding: $338,000 direct costs for up to 4 years; this includes up to $69,000 per year, for up to two years, for each postdoctoral year in direct costs and up to $100,000 per year, for up to two years, for faculty-level position years in direct costs
The Tuberous Sclerosis Complex Research Program (TSCRP) Career Transition Award supports TSC researchers during the transition from postdoctoral training to an independent position.  This award will cover up to two years of postdoctoral training followed by up to two years of a faculty-level position. For the purposes of this award, the postdoctoral candidate is considered the Principal Investigator (PI).

NIH Announcements:

Functional Links between the Immune System, Brain Function and Behavior
(PA-08-097) - R01
(PA-08-098) - R21
National Cancer Institute
Application Receipt Date: June 5, 2008 for R01; June 16, 2008 for R21
Funding: size and duration vary, but standard NIH modular rules apply.
This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI) solicits research grant applications to study neuroimmune molecules and mechanisms involved in regulating normal and pathological functions of the central nervous system (CNS).

Optimizing Technologies for the Preservation of Fertility (R21)
(PAR-08-105)
National Cancer Institute
Application Receipt Date: September 16, 2008
Funding: $275,000 for 2 years
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the National Cancer Institute (NCI) of the National Institutes of Health (NIH) solicit Exploratory/Developmental (R21) grant applications that propose to develop or enhance technologies designed to increase the fertility preservation options for individuals who are or may become infertile secondary to chronic disease or disease treatment, exposure to environmental or occupational hazards, advanced reproductive age, or genetic predisposition.

March 4

Department of Defense Ovarian Cancer Research Program
Department of Defense
Deadline: Pre-application: March 26, 2008; proposal: July 2, 2008
The DoD Ovarian Cancer Research Program (OCRP) has received $10 million for fiscal year 2008. Several funding mechanisms are available: Idea Development Award, Translational Partnership Award, Career Development Award, and the Consortium Development Award. Please click on the link for more information about each funding mechanism.